Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

Presentation AHA 2017

Time at Blood Pressure Target and the Risk of Cardiovascular Diseases and Mortality

Presenter: Mar Pujades-Rodriguez

November 14, 2017

Presentation AHA 2017

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program

Presenter: Kenneth W. Mahaffey

November 14, 2017

Presentation AHA 2017

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Presenter: Steven Weisbord

November 13, 2017

Presentation TCT 2017

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Presenter: Somjot S. Brar, Roxana Mehran, Ran Kornowski

November 01, 2017

Presentation TCT 2017

Feasibility of PCI With No Contrast

Presenter: Patricia J. Best, Somjot S. Brar, Ziad A. Ali

November 01, 2017

Presentation TCT 2017

Strategies to Optimize Hydration for CIN Prevention

Presenter: Patricia J. Best, Somjot S. Brar

November 01, 2017

Presentation TCT 2017

Contrast Reduction Strategies in the Patient With CKD

Presenter: Patricia J. Best, Somjot S. Brar, Roxana Mehran

November 01, 2017

Presentation TCT 2017

CIN Risk Prediction and Contrast Volume: Data and Guidelines

Presenter: Patricia J. Best, Somjot S. Brar, Hitinder S. Gurm

November 01, 2017

Presentation TCT 2017

Contrast Induced Nephropathy: Why Does It Matter?

Presenter: Patricia J. Best, Somjot S. Brar, Carlo Briguori

November 01, 2017

Presentation TCT 2017

Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Kolja Sievert

October 31, 2017

Presentation TCT 2017

Device Embolization: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Brian K. Whisenant

October 31, 2017

Presentation TCT 2017

Periprocedural Effusions and Tamponade: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Martin W. Bergmann

October 31, 2017

Presentation TCT 2017

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Presenter: Vinayak Bapat, Maurice Buchbinder, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

Keynote Address: The Spectrum Of TMVR Complications - Frequency, Implications, and Prevention and Treatment

Presenter: Vinayak Bapat, Maurice Buchbinder, Neil E. Moat

October 31, 2017

Presentation TCT 2017

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo

October 31, 2017

Presentation TCT 2017

TCT 63: A Novel Patent Hemostasis Protocol - Prevention of Pseudoaneurysm After Transpedal Arterial Access for Evaluation and Treatment of Peripheral Arterial Disease

Presenter: Mark C. Bates, Dharam J. Kumbhani, Apurva Patel, MD

October 31, 2017

Presentation TCT 2017

High-Risk AF Patients: Changing the Emphasis From Stroke Prevention to Stroke and Hemorrhagic Complication Avoidance

Presenter: Christopher B. Granger, Horst Sievert, Michael D. Ezekowitz

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

Cerebral Protection During TAVR: Routine vs Selective Use

Presenter: David Hildick-Smith, Lars Sondergaard, Axel Linke

October 29, 2017

Advertisement

Time at Blood Pressure Target and the Risk of Cardiovascular Diseases and Mortality

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Feasibility of PCI With No Contrast

Strategies to Optimize Hydration for CIN Prevention

Contrast Reduction Strategies in the Patient With CKD

CIN Risk Prediction and Contrast Volume: Data and Guidelines

Contrast Induced Nephropathy: Why Does It Matter?

Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews)

Device Embolization: Frequency, Prevention, and Treatment (With Case Reviews)

Periprocedural Effusions and Tamponade: Frequency, Prevention, and Treatment (With Case Reviews)

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Keynote Address: The Spectrum Of TMVR Complications - Frequency, Implications, and Prevention and Treatment

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

TCT 63: A Novel Patent Hemostasis Protocol - Prevention of Pseudoaneurysm After Transpedal Arterial Access for Evaluation and Treatment of Peripheral Arterial Disease

High-Risk AF Patients: Changing the Emphasis From Stroke Prevention to Stroke and Hemorrhagic Complication Avoidance

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

Cerebral Protection During TAVR: Routine vs Selective Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content